Liang Zhou
6PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 08, 2024
Combined MEK1/2 and ATR inhibition promotes myeloma cell death through a STAT3-dependent mechanism in vitro and in vivo.Lin Li, Xiaoyan Hu, Jewel Nkwocha
|May 01, 2023
Non-canonical role for the ataxia-telangiectasia-Rad3 pathway in STAT3 activation in human multiple myeloma cells.Lin Li, Xiaoyan Hu, Jewel Nkwocha
|Feb 22, 2023
Synergistic Interactions between the Hypomethylating Agent Thio-Deoxycytidine and Venetoclax in Myelodysplastic Syndrome Cells.Xiaoyan Hu, Lin Li, Jewel Nkwocha
|Jan 18, 2023
Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax.Toshihisa Satta, Lin Li, Sri Lakshmi Chalasani
|Nov 16, 2021
Chk1 Inhibition Potently Blocks STAT3 Tyrosine705 Phosphorylation, DNA-Binding Activity, and Activation of Downstream Targets in Human Multiple Myeloma Cells.Liang Zhou, Xinyan Pei, Yu Zhang
|Aug 31, 2021
IAP and HDAC inhibitors interact synergistically in myeloma cells through noncanonical NF-κB- and caspase-8-dependent mechanisms.Liang Zhou, Yu Zhang, Mark B Meads
Pageof 1
Frequent Collaborators
4 joint publications
Steven Grant
2 joint publications
Sri Lakshmi Chalasani
1 joint publications
Rebecca Parker
1 joint publications
Praneeth R Sudalagunta
1 joint publications
Rafael R Canevarolo
1 joint publications
Jonathan Yu
1 joint publications
Toshihisa Satta
1 joint publications
Lin Li
1 joint publications
Xiaoyan Hu
1 joint publications
Jewel Nkwocha
